The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
 
Matthew B. Yurgelun
No Relationships to Disclose
 
C. Sloane Furniss
No Relationships to Disclose
 
Barbara Kenner
No Relationships to Disclose
 
Alison Klein
Consulting or Advisory Role - OptumInsight
 
Catherine C. Lafferty
No Relationships to Disclose
 
Andrew M. Lowy
Honoraria - Celgene
Consulting or Advisory Role - Halozyme; Merck; PFizer
Research Funding - Mitsubishi Tanabe Pharma; Syros Pharmaceuticals
Expert Testimony - Merck
Travel, Accommodations, Expenses - Pfizer
 
Florencia McAllister
No Relationships to Disclose
 
Maureen E Mork
No Relationships to Disclose
 
Scott H. Nelson
No Relationships to Disclose
 
Alison Robertson
No Relationships to Disclose
 
Jill E. Stopfer
No Relationships to Disclose
 
Meghan Underhill
No Relationships to Disclose
 
Allyson J. Ocean
No Relationships to Disclose
 
Lisa Madlensky
Employment - Janssen (I)
Patents, Royalties, Other Intellectual Property - Husband has patents through his employment with Janssen. These are methods patents and not related to any therapeutics. (I)
 
Gloria M. Petersen
No Relationships to Disclose
 
Judy Ellen Garber
Consulting or Advisory Role - GTx (I); Helix BioPharma; Novartis (I); ORIC Pharmaceuticals (I); pfizer (I); SV Life Sciences (I)
Research Funding - Ambry Genetics; Novartis (I)
Other Relationship - AACR; Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Global Biological Standards Institute (I); James P. Wilmot Foundation (I); Susan G. Komen for the Cure (I)
 
Scott Michael Lippman
No Relationships to Disclose
 
Michael Goggins
Patents, Royalties, Other Intellectual Property - Royalty related to licensing as a codiscoverer of PALB2 as a pancreatic cancer susceptibility gene to Myriad Genetics
 
Anirban Maitra
Honoraria - Celgene
 
Sapna Syngal
Consulting or Advisory Role - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Travel, Accommodations, Expenses - Myriad Genetics